Intraretinal vessel treatment for central retinal vein occlusio
Phase 2
Recruiting
- Conditions
- Cetntral Retinal Artery and Vein Occlusion
- Registration Number
- JPRN-UMIN000007958
- Lead Sponsor
- Intraretinal vessel treatment for central retinal vein occlusion study team
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Key exclusion criteria included CRVO with neovascularization, any previous treatment for CRVO, intraocular surgery during the previous 3 months, vascular retinopathy arising from other causes, glaucoma with an advanced visual field defect or uncontrolled ocular hypertension (25 mmHg) despite full therapy, and myocardial infarction or stroke during the last 12 months. All the participants provided their written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity (ETDRS charts), Retinal thickness
- Secondary Outcome Measures
Name Time Method